{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:40:10Z","timestamp":1793094010411,"version":"4.5.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>A critical tool in the successful management of patients with abnormal placentation is an established massive transfusion protocol designed to rapidly deliver blood products in obstetrical and surgical hemorrhage. Spurred by trauma research and an understanding of consumptive coagulopathy, the past 2 decades have seen a shift in volume resuscitation from an empiric, crystalloid-based method to balanced, targeted transfusion therapy. The present article reviews patient blood management in abnormal placentation, beginning with optimizing the patient\u2019s status in the antenatal period to the laboratory assessment and transfusion strategy for blood products at the time of hemorrhage.<\/jats:p>","DOI":"10.1097\/grf.0000000000000400","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:21:12Z","timestamp":1538612472000},"page":"828-840","source":"Crossref","is-referenced-by-count":13,"title":["Blood Products in the Management of Abnormal Placentation"],"prefix":"10.1097","volume":"61","author":[{"given":"LUKE A.","family":"GATTA","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EVELYN L.","family":"LOCKHART","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of New Mexico, Albuquerque, New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDRA H.","family":"JAMES","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0002-9378(90)90834-T","article-title":"Changes in uterine blood flow during human pregnancy","volume":"162","author":"Thaler","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/AOG.0000000000000722","article-title":"Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage","volume":"125","author":"Mehrabadi","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/AOG.0b013e318262e340","article-title":"Committee opinion no. 529: placenta accreta","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R5-20230911","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1111\/j.1537-2995.2011.03205.x","article-title":"Transfusion requirements in obstetric patients with placenta accreta","volume":"51","author":"Stotler","year":"2011","journal-title":"Transfusion"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-2000-9269","article-title":"Maternal complications with placenta previa","volume":"17","author":"Crane","year":"2000","journal-title":"Am J Perinatol"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/AOG.0b013e3181df94e8","article-title":"Regionalization of care for obstetric hemorrhage and its effect on maternal mortality","volume":"115","author":"Wright","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"pt 1","key":"R8-20230911","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/AOG.0b013e3182051db2","article-title":"Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care","volume":"117","author":"Eller","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ajog.2014.11.018","article-title":"Center of excellence for placenta accreta","volume":"212","author":"Silver","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/trf.12550","article-title":"Evaluation and management of postpartum hemorrhage: consensus from an international expert panel","volume":"54","author":"Abdul-Kadir","year":"2014","journal-title":"Transfusion"},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/ACO.0000000000000463","article-title":"Strategies to reduce blood product utilization in obstetric practice","volume":"30","author":"Neb","year":"2017","journal-title":"Curr Opin Anaesthesiol"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/OGX.0000000000000510","article-title":"Anemia in pregnancy: a pragmatic approach","volume":"72","author":"Sun","year":"2017","journal-title":"Obstet Gynecol Surv"},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/trf.13426","article-title":"How do we develop and implement a preoperative anemia clinic designed to improve perioperative outcomes and reduce cost?","volume":"56","author":"Guinn","year":"2016","journal-title":"Transfusion"},{"key":"R14-20230911","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/AOG.0b013e3181809c0d","article-title":"ACOG Practice Bulletin No. 95: anemia in pregnancy","volume":"112","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2141.2011.09012.x","article-title":"UK guidelines on the management of iron deficiency in pregnancy","volume":"156","author":"Pavord","year":"2012","journal-title":"Br J Haematol"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1537-2995.2003.00348.x","article-title":"Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe","volume":"43","author":"Rosencher","year":"2003","journal-title":"Transfusion"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0033-1357492","article-title":"Preoperative blood management strategies for total knee arthroplasty","volume":"26","author":"Kapadia","year":"2013","journal-title":"J Knee Surg"},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0301-2115(95)02538-3","article-title":"Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy","volume":"69","author":"al-Momen","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1067\/mob.2002.121894","article-title":"Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route","volume":"186","author":"Bayoumeu","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R21-20230911","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/01.AOG.0000185260.82466.b4","article-title":"Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial","volume":"106","author":"Al","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13224-012-0222-0","article-title":"Iron deficiency anemia in pregnancy: intravenous versus oral route","volume":"62","author":"Shafi","year":"2012","journal-title":"J Obstet Gynaecol India"},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3109\/14767058.2012.746299","article-title":"Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial","volume":"26","author":"Froessler","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R24-20230911","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1447-0756.2012.01982.x","article-title":"Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial","volume":"39","author":"Kochhar","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00277-014-2189-7","article-title":"Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia","volume":"94","author":"Shi","year":"2015","journal-title":"Ann Hematol"},{"key":"R26-20230911","doi-asserted-by":"crossref","first-page":"1178626417737738","DOI":"10.1177\/1178626417737738","article-title":"Prophylactic iron supplementation in pregnancy: a controversial issue","volume":"10","author":"Friedrisch","year":"2017","journal-title":"Biochem Insights"},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinte.158.6.610","article-title":"Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators","volume":"158","author":"Forgie","year":"1998","journal-title":"Arch Intern Med"},{"key":"R28-20230911","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tmrv.2015.04.001","article-title":"Preoperative autologous blood donation: waning indications in an era of improved blood safety","volume":"29","author":"Vassallo","year":"2015","journal-title":"Transfus Med Rev"},{"key":"R29-20230911","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.0958-7578.2004.00529.x","article-title":"Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: a case report and review of the literature","volume":"14","author":"Covin","year":"2004","journal-title":"Transfus Med"},{"key":"R30-20230911","first-page":"125","article-title":"Autologous blood in obstetrics: where are we going now?","volume":"10","author":"Liumbruno","year":"2012","journal-title":"Blood Transfus"},{"key":"R31-20230911","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/jp.2013.185","article-title":"Does previa location matter? Surgical morbidity associated with location of a placenta previa","volume":"34","author":"Young","year":"2014","journal-title":"J Perinatol"},{"key":"R32-20230911","first-page":"155","article-title":"National partnership for maternal safety: consensus bundle on obstetric hemorrhage","volume":"126","author":"Main","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R33-20230911","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1537-2995.2010.02753.x","article-title":"Development of a rapid emergency hemorrhage panel","volume":"50","author":"Chandler","year":"2010","journal-title":"Transfusion"},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R35-20230911","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2014-04-567891","article-title":"Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study","volume":"124","author":"Collins","year":"2014","journal-title":"Blood"},{"key":"R36-20230911","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jth.13174","article-title":"Subcommittees on Women\u2019 s Health Issues in T, Haemostasis, on disseminated intravascular c. management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH","volume":"14","author":"Collins","year":"2016","journal-title":"J Thromb Haemost"},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/1471-0528.14178","article-title":"Prevention and management of postpartum haemorrhage: green-top guideline no. 52","volume":"124","author":"Mavrides","year":"2017","journal-title":"BJOG"},{"key":"R38-20230911","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tjog.2017.10.001","article-title":"A systematic review of massive transfusion protocol in obstetrics","volume":"56","author":"Tanaka","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/bja\/aex181","article-title":"Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial","volume":"119","author":"Collins","year":"2017","journal-title":"Br J Anaesth"},{"key":"R40-20230911","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ccc.2016.08.003","article-title":"Coagulopathy of trauma","volume":"33","author":"Cohen","year":"2017","journal-title":"Crit Care Clin"},{"key":"R41-20230911","first-page":"CD007871","article-title":"Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion","author":"Afshari","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R42-20230911","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jclinane.2017.10.003","article-title":"Point-of-care viscoelastic testing improves the outcome of pregnancies complicated by severe postpartum hemorrhage","volume":"44","author":"Snegovskikh","year":"2018","journal-title":"J Clin Anesth"},{"key":"R43-20230911","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13049-016-0308-2","article-title":"A systematic review on the rotational thrombelastometry (ROTEM(R)) values for the diagnosis of coagulopathy, prediction and guidance of blood transfusion and prediction of mortality in trauma patients","volume":"24","author":"Veigas","year":"2016","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"R44-20230911","first-page":"CD007871","article-title":"Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding","author":"Wikkelso","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R45-20230911","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijgo.2006.02.014","article-title":"Drape estimation vs. visual assessment for estimating postpartum hemorrhage","volume":"93","author":"Patel","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"R46-20230911","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/SIH.0b013e318230604f","article-title":"Decay in blood loss estimation skills after web-based didactic training","volume":"7","author":"Toledo","year":"2012","journal-title":"Simul Healthc"},{"key":"R47-20230911","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/AOG.0000000000000322","article-title":"Executive summary of the reVITALize initiative: standardizing obstetric data definitions","volume":"124","author":"Menard","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R48-20230911","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/1552-6909.12723","article-title":"National Partnership for Maternal Safety: consensus bundle on obstetric hemorrhage","volume":"44","author":"Main","year":"2015","journal-title":"J Obstet Gynecol Neonatal Nur"},{"issue":"suppl 6","key":"R50-20230911","first-page":"S36","article-title":"Damage control resuscitation","volume":"62","author":"Holcomb","year":"2007","journal-title":"J Trauma"},{"key":"R51-20230911","first-page":"307","article-title":"Damage control resuscitation: directly addressing the early coagulopathy of trauma","volume":"62","author":"Holcomb","year":"2007","journal-title":"J Trauma"},{"issue":"suppl 1","key":"R52-20230911","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/TA.0b013e31828fa3b9","article-title":"Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study","volume":"75","author":"del Junco","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"R53-20230911","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"R54-20230911","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/ALN.0b013e3181f22b5a","article-title":"Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution","volume":"113","author":"Bolliger","year":"2010","journal-title":"Anesthesiology"},{"key":"R55-20230911","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ajog.2014.07.012","article-title":"Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety","volume":"212","author":"Shields","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 1","key":"R56-20230911","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/SHK.0000000000000088","article-title":"An update on the coagulopathy of trauma","volume":"41","author":"Maegele","year":"2014","journal-title":"Shock"},{"key":"R57-20230911","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/01.TA.0000064328.97941.FC","article-title":"A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function","volume":"56","author":"Wolberg","year":"2004","journal-title":"J Trauma"},{"key":"R58-20230911","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/TA.0b013e31825c163b","article-title":"Hypothermia in massive transfusion","volume":"73","author":"Reynolds","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"R59-20230911","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1213\/ANE.0000000000000786","article-title":"Cell salvage in obstetrics","volume":"121","author":"Goucher","year":"2015","journal-title":"Anesth Analg"},{"key":"R60-20230911","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00000542-200006000-00008","article-title":"Amniotic fluid removal during cell salvage in the cesarean section patient","volume":"92","author":"Waters","year":"2000","journal-title":"Anesthesiology"},{"key":"R61-20230911","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijoa.2013.05.007","article-title":"The use of cell salvage in women undergoing cesarean hysterectomy for abnormal placentation","volume":"22","author":"Elagamy","year":"2013","journal-title":"Int J Obstet Anesth"},{"key":"R62-20230911","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tmrv.2009.03.001","article-title":"Cryoprecipitate: the current state of knowledge","volume":"23","author":"Callum","year":"2009","journal-title":"Transfus Med Rev"},{"key":"R64-20230911","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/aogs.12063","article-title":"Transfusion practices in postpartum hemorrhage: a population-based study","volume":"92","author":"Bonnet","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R65-20230911","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/j.1537-2995.2008.01858.x","article-title":"A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions","volume":"48","author":"Kennedy","year":"2008","journal-title":"Transfusion"},{"key":"R66-20230911","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00062752-199911000-00012","article-title":"Pathophysiology of febrile nonhemolytic transfusion reactions","volume":"6","author":"Heddle","year":"1999","journal-title":"Curr Opin Hematol"},{"key":"R67-20230911","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.hoc.2017.08.014","article-title":"Blood product transfusions and reactions","volume":"31","author":"Osterman","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"key":"R68-20230911","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1537-2995.2006.00930.x","article-title":"Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study","volume":"46","author":"Rana","year":"2006","journal-title":"Transfusion"},{"issue":"suppl","key":"R69-20230911","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1097\/01.CCM.0000214293.72918.D8","article-title":"Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies","volume":"34","author":"Curtis","year":"2006","journal-title":"Crit Care Med"},{"key":"R70-20230911","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tmrv.2017.07.001","article-title":"Analysis of transfusion-related acute lung injury and possible transfusion-related acute lung injury reported to the french hemovigilance network from 2007 to 2013","volume":"32","author":"Andreu","year":"2018","journal-title":"Transfus Med Rev"},{"key":"R72-20230911","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood.V69.2.460.460","article-title":"Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors","volume":"69","author":"Kruithof","year":"1987","journal-title":"Blood"},{"key":"R73-20230911","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"R74-20230911","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"R75-20230911","first-page":"CD007872","article-title":"Tranexamic acid for preventing postpartum haemorrhage","author":"Novikova","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R76-20230911","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc10143","article-title":"High-dose tranexamic acid reduces blood loss in postpartum haemorrhage","volume":"15","author":"Ducloy-Bouthors","year":"2011","journal-title":"Crit Care"},{"key":"R77-20230911","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00404-012-2593-y","article-title":"Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial","volume":"287","author":"Xu","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"R78-20230911","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/AOG.0000000000002253","article-title":"Tranexamic acid for the management of obstetric hemorrhage","volume":"130","author":"Pacheco","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R79-20230911","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/aogs.12798","article-title":"Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Simonazzi","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R80-20230911","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.athoracsur.2012.02.037","article-title":"Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations","volume":"93","author":"Andersen","year":"2012","journal-title":"Ann Thorac Sur"},{"key":"R81-20230911","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1213\/ANE.0b013e3181c039e6","article-title":"Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry","volume":"109","author":"Phillips","year":"2009","journal-title":"Anesth Analg"},{"key":"R82-20230911","first-page":"86","article-title":"The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII","volume":"13","author":"Zatta","year":"2015","journal-title":"Blood Transfus"},{"key":"R83-20230911","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/EJA.0b013e32835f4d5b","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology","volume":"30","author":"Kozek-Langenecker","year":"2013","journal-title":"Eur J Anaesthesiol"},{"key":"R84-20230911","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.TA.0000066184.20808.A5","article-title":"The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients","volume":"55","author":"Meng","year":"2003","journal-title":"J Trauma"},{"key":"R85-20230911","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/bja\/aen270","article-title":"Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations","volume":"101","author":"Fenger-Eriksen","year":"2008","journal-title":"Br J Anaesth"},{"key":"R86-20230911","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijoa.2009.08.004","article-title":"The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage","volume":"19","author":"Bell","year":"2010","journal-title":"Int J Obstet Anesth"},{"key":"R87-20230911","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2044.2010.06548.x","article-title":"Fibrinogen concentrate use during major obstetric haemorrhage","volume":"65","author":"Glover","year":"2010","journal-title":"Anaesthesia"},{"key":"R88-20230911","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.accpm.2015.10.011","article-title":"Fibrinogen concentrate as a treatment for postpartum haemorrhage-induced coagulopathy: A study protocol for a randomised multicentre controlled trial. The fibrinogen in haemorrhage of DELivery (FIDEL) trial","volume":"35","author":"Ducloy-Bouthors","year":"2016","journal-title":"Anaesth Crit Care Pain Med"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201812000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:08:46Z","timestamp":1694477326000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201812000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000400","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}